Acadia Pharma delays seeking approval of Parkinson’s Drug; CEO retires
March 11, 2015 at 17:36 PM EDT
Acadia Pharmaceuticals Inc. won’t be seeking regulatory approval for its lead drug candidate to treat Parkinson’s disease psychosis until the second half of the year.
